Virological Outcome Measures During Analytical Treatment Interruptions in Chronic HIV-1-Infected Patients.

Journal: Open forum infectious diseases
Published Date: Nov 3, 2019

Abstract

BACKGROUND: Analytical treatment interruptions (ATIs) are essential in research on HIV cure. However, the heterogeneity of virological outcome measures used in different trials hinders the interpretation of the efficacy of different strategies.

Authors

  • Csaba Fehér
    Institute for Research in Biomedicine (IRB Barcelona), the Barcelona Institute for Science and Technology, Barcelona, Spain.
  • Lorna Leal
    Infectious Diseases Department, Hospital Clinic of Barcelona - HIVACAT, University of Barcelona, Barcelona, Spain.
  • Montserrat Plana
    Retrovirology and Viral Immunopathology Laboratory, AIDS Research Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS) - HIVACAT, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
  • Nuria Climent
    Retrovirology and Viral Immunopathology Laboratory, AIDS Research Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS) - HIVACAT, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
  • Alberto Crespo Guardo
    Retrovirology and Viral Immunopathology Laboratory, AIDS Research Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS) - HIVACAT, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
  • Esteban Martínez
    Infectious Diseases Department, Hospital Clinic of Barcelona - HIVACAT, University of Barcelona, Barcelona, Spain.
  • Pedro Castro
    Infectious Diseases Department, Hospital Clinic of Barcelona - HIVACAT, University of Barcelona, Barcelona, Spain.
  • Vicens Díaz-Brito
    Infectious Diseases Department, Hospital Clinic of Barcelona - HIVACAT, University of Barcelona, Barcelona, Spain.
  • Beatriz Mothe
    IrsiCaixa AIDS Research Institute, Badalona, Spain.
  • Juan Carlos López Bernaldo De Quirós
    HIV/Infectious Diseases Unit, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Josep María Gatell
    Infectious Diseases Department, Hospital Clinic of Barcelona - HIVACAT, University of Barcelona, Barcelona, Spain.
  • Patrick Aloy
    Institute for Research in Biomedicine (IRB Barcelona), the Barcelona Institute for Science and Technology, Barcelona, Spain.
  • Felipe García
    Infectious Diseases Department, Hospital Clinic of Barcelona - HIVACAT, University of Barcelona, Barcelona, Spain.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals